Pharsight

Drugs that contain Nimodipine

1. Nymalize patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7070581 AZURITY Dispenser for medicaments and method and apparatus for making same
Jun, 2023

(11 months ago)

US8517997 AZURITY Dispenser for medicaments and method and apparatus for making same
May, 2024

(30 days ago)

US11413277 AZURITY Non-aqueous liquid nimodipine compositions
Apr, 2038

(13 years from now)

US10342787 AZURITY Non-aqueous liquid nimodipine compositions
Apr, 2038

(13 years from now)

US10576070 AZURITY Non-aqueous liquid nimodipine compositions
Apr, 2038

(13 years from now)

US11207306 AZURITY Non-aqueous liquid nimodipine compositions
Apr, 2038

(13 years from now)

US11517563 AZURITY Liquid nimodipine compositions
Apr, 2038

(13 years from now)

US11806338 AZURITY Non-aqueous liquid nimodipine compositions
Apr, 2038

(13 years from now)

US11759457 AZURITY Liquid nimodipine compositions
Apr, 2038

(13 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-46) May 10, 2020
Orphan Drug Exclusivity(ODE) May 10, 2020

Market Authorisation Date: 10 May, 2013

Treatment: A method for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (sah) from ruptured intracranial berry a...

Dosage: SOLUTION;ORAL

How can I launch a generic of NYMALIZE before it's drug patent expiration?
More Information on Dosage

NYMALIZE family patents

Family Patents